NEW YORK (GenomeWeb) – Consumer genomics company 23andMe let customers know this week that it will restrict its application programming interface (API) to select third-party apps.
The firm said that in two weeks it would disable other apps' ability to access customers' 23andMe results through its API. In effect, customers that have shared their 23andMe reports with other apps through its API may no longer work.